Preventing Relapse to Smoking Among Prisoners After Release
NCT ID: NCT04271371
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2019-08-08
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prolonged Smoking Cessation Using Prescription Step Care
NCT00170079
Evaluating Specific Plans to Increase Smoking Quit Attempts in Prison
NCT02567097
To Examine Smoking Behavior of Prisoners - 1
NCT00115674
Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention
NCT01305447
Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households
NCT01625468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Document the support provided to manage nicotine addiction during imprisonment and in the periods immediately before and after release; establish the extent to which prisoners intentionally resume or unintentionally relapse to smoking after release; and obtain views on how relapse might be prevented.
2. Drawing on current literature and findings from Phase 1, develop and design an prototype intervention to prevent smoking relapse after release.
3. To pilot the designed prototype intervention and conduct a process evaluation to inform the development of further work in this area.
The research will be carried out in three prisons in the East Midlands. The main duties will include recruitment of participants (HMPPS staff members and prisoners), data collection, data analysis, assist with intervention development and refining related intervention materials/resources, co-facilitate Patient and Public Involvement (PPI) groups, contribute to the ethical application for the pilot intervention, and preparation of manuscripts for peer-review publication.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prototype intervention
To be developed through Phase 1 and 2
Not yet developed
A prototype intervention will be developed over Phase 1 \& 2 and piloted in Phase 3 of this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Not yet developed
A prototype intervention will be developed over Phase 1 \& 2 and piloted in Phase 3 of this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are currently residing in one of the three study sites (HMPs Nottingham, Ranby and Sudbury)
* Male (women will not be held at any of the study sites)
* Have a provisional release date within the next 2 months.
* Are capable of understanding and consenting to the study.
* Remand and sentenced prisoners.
* Who report that they are a current smoker and/or a current smoker prior to entering prison (smoked up to 7 days before entering prison), and/or were in prison (and still on the same sentence) and a current smoker prior to the smoke-free prison policy.
3\. Reception prisoner cross-sectional
* All participants are aged 18 or over (no upper age limit)
* Are currently residing in the open prison study site (HMP Sudbury)
* Male (women will not be held at any of the study sites)
* Have been in the open prison more than two weeks but for less than 3 months.
* Have been transferred from a closed prison.
* Are capable of understanding and consenting to the study.
* Sentenced prisoners.
* Who report that they were a current smoker prior to entering prison (smoked up to 7 days before entering prison), and/or were in prison (and still on the same sentence) and a current smoker prior to the smoke-free prison policy.
Exclusion Criteria
* Non-smokers.
* Being deported post release.
* Been in prison for less than four weeks.
3\. Reception prisoner cross-sectional
* Present a serious risk of harm to the researchers, highlighted in PNOMIS records or by a member of staff.
* Been in prison for less than 2 weeks.
* Non-smokers.
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Her Majesty's Prison and Probation Service (HMPPS)
UNKNOWN
Public Health England
OTHER_GOV
Cancer Research UK
OTHER
Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
UNKNOWN
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Nottingham, School of Medicine
Nottingham, Please Select, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
254028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.